Findings

What do systematic reviews say?

3,241 questions · 3,336 findings · 1,340 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1,581 · 47.4%GRADE not reported 352 · 10.6%Very low 512 · 15.3%Low 509 · 15.3%Moderate 316 · 9.5%High 66 · 2%

Scheduled PDE5I vs on demand PDE5I

Sexual quality of life · post‐prostatectomy erectile dysfunction (long‐term)

1 finding from 1 review

Penile rehabilitation for postprostatectomy erectile dysfunction 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 281 participants
Moderate

Intervention not reported

Quality of life (AQLQ) · adults with asthma

1 finding from 1 review

Long‐acting muscarinic antagonists (LAMA) added to combination long‐acting beta₂‐agonists and inhaled corticosteroids… 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 907 participants
High

LAMA add‐on vs ICS alone

Health‐related quality of life (AQLQ)Scale from: 1‐7 (higher is better) · adults with asthma not well controlled on ICS

1 finding from 1 review

Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for… 2015 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 1713 participants
High

Intervention not reported

Quality of life SGRQ ( · exacerbations of COPD

1 finding from 1 review

Hospital at home for acute exacerbations of chronic obstructive pulmonary disease 2012 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 332 participants
Very low

Tiotropium vs long‐acting beta‐agonists

SGRQ Total SGRQ (Total) Score. Scale from: 0 to 100. Lower score indicates better quality of life. · patients with stable chronic obstructive pulmonary disease and > 10 pack years smoking history

1 finding from 1 review

Tiotropium versus long‐acting beta‐agonists for stable chronic obstructive pulmonary disease 2012 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 4935 participants
GRADE not reported

Corticosteroids vs placebo

QoL · adults with advanced cancer and cancer‐related fatigue

1 finding from 1 review

Corticosteroids for the management of cancer‐related fatigue in adults with advanced cancer 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 118 participants
Very low

Summary of findings table ‐ Adjunctive therapies in addition to land‐based exercise therapy vs land‐based exercise therapy

Quality of life ‐ total · Patients with osteoarthritis of the knee or hip

1 finding from 1 review

Adjunctive therapies in addition to land‐based exercise therapy for osteoarthritis of the hip or knee 2022 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 1483 participants
Very low

Palmitoylethanolamide and luteolin vs no intervention

Generic quality of life measures · adults with olfactory dysfunction for ≥ 4 weeks following COVID‐19 infection

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the treatment of persistent post‐COVID‐19 olfactory dysfunction 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Systemic corticosteroids plus intranasal steroid/mucolytic/decongestant vs no intervention

Generic quality of life measures · adults with olfactory dysfunction for ≥ 4 weeks following COVID‐19 infection

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the treatment of persistent post‐COVID‐19 olfactory dysfunction 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Multidisciplinary disease management programmes vs usual care

Quality of life (MLHFQ): from 0 to 105 · adults with heart failure

1 finding from 1 review

Disease management interventions for heart failure 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 140 participants
Very low

Surgery plus whole brain radiotherapy (WBRT) vs stereotactic radiosurgery plus WBRT

Health‐related quality of life (HRQoL) · people with single or solitary brain metastasis

1 finding from 1 review

Surgery versus stereotactic radiotherapy for people with single or solitary brain metastasis 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 14 participants
Very low

Surgery plus whole brain radiotherapy (WBRT) vs stereotactic radiosurgery

Health‐related quality of life (HRQoL) · people with single or solitary brain metastasis

1 finding from 1 review

Surgery versus stereotactic radiotherapy for people with single or solitary brain metastasis 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1 participants
Very low

Macrolides vs placebo

Quality of life: change · adults with bronchiectasis

1 finding from 1 review

Macrolide antibiotics for bronchiectasis 2018 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 305 participants
Low

1% pimecrolimus cream vs betamethasone 17‐valerate 0.1%

Quality of life measure · people with discoid lupus erythematosus

The review found no eligible studies for this question.

1 finding from 1 review

Drugs for discoid lupus erythematosus 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

R‐salbutamol 0.5% topical cream vs placebo

Quality of life measure · people with discoid lupus erythematosus

The review found no eligible studies for this question.

1 finding from 1 review

Drugs for discoid lupus erythematosus 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Tacrolimus 0.1% cream vs placebo

Quality of life measure · people with discoid lupus erythematosus

The review found no eligible studies for this question.

1 finding from 1 review

Drugs for discoid lupus erythematosus 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Fluocinonide 0.05% vs hydrocortisone 1%

Quality of life measure · people with discoid lupus erythematosus

The review found no eligible studies for this question.

1 finding from 1 review

Drugs for discoid lupus erythematosus 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Acitretin 50 mg daily vs hydroxychloroquine 400 mg daily

Quality of life measure · people with discoid lupus erythematosus

The review found no eligible studies for this question.

1 finding from 1 review

Drugs for discoid lupus erythematosus 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Non‐invasive ventilation vs usual care

Quality of life (SAQLI) · people with ALS

1 finding from 1 review

Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 41 participants
Low

GnRH‐a + raloxifene vs GnRH‐a ± placebo

QoL · patients with uterine fibroids

1 finding from 1 review

Add‐back therapy with GnRH analogues for uterine fibroids 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 74 participants
Low